Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy
Top Cited Papers
Open Access
- 1 September 2009
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 119 (9) , 2623-2633
- https://doi.org/10.1172/jci38660
Abstract
Caveolae are invaginations of the plasma membrane involved in many cellular processes, including clathrin-independent endocytosis, cholesterol transport, and signal transduction. They are characterized by the presence of caveolin proteins. Mutations that cause deficiency in caveolin-3, which is expressed exclusively in skeletal and cardiac muscle, have been linked to muscular dystrophy. Polymerase I and transcript release factor (PTRF; also known as cavin) is a caveolar-associated protein suggested to play an essential role in the formation of caveolae and the stabilization of caveolins. Here, we identified PTRF mutations in 5 nonconsanguineous patients who presented with both generalized lipodystrophy and muscular dystrophy. Muscle hypertrophy, muscle mounding, mild metabolic complications, and elevated serum creatine kinase levels were observed in these patients. Skeletal muscle biopsies revealed chronic dystrophic changes, deficiency and mislocalization of all 3 caveolin family members, and reduction of caveolae structure. We generated expression constructs recapitulating the human mutations; upon overexpression in myoblasts, these mutations resulted in PTRF mislocalization and disrupted physical interaction with caveolins. Our data confirm that PTRF is essential for formation of caveolae and proper localization of caveolins in human cells and suggest that clinical features observed in the patients with PTRF mutations are associated with a secondary deficiency of caveolins.This publication has 40 references indexed in Scilit:
- Heterozygous CAV1 frameshift mutations (MIM 601047) in patients with atypical partial lipodystrophy and hypertriglyceridemiaLipids in Health and Disease, 2008
- AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34Nature Genetics, 2002
- Caveolin-1-deficient Mice Are Lean, Resistant to Diet-induced Obesity, and Show Hypertriglyceridemia with Adipocyte AbnormalitiesJournal of Biological Chemistry, 2002
- Impairment of Caveolae Formation and T-System Disorganization in Human Muscular Dystrophy with Caveolin-3 DeficiencyThe American Journal of Pathology, 2002
- Emerging Themes in Lipid Rafts and CaveolaeCell, 2001
- Identification of the gene altered in Berardinelli–Seip congenital lipodystrophy on chromosome 11q13Nature Genetics, 2001
- Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle diseaseNature Genetics, 2001
- Transgenic mice expressing mutant caveolin-3 show severe myopathy associated with increased nNOS activity.Human Molecular Genetics, 2001
- Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophyHuman Molecular Genetics, 2000
- Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertensionNature, 1999